Cannabis research: Risks of recreational use and potential medical applications.
作者信息
Maldonado Rafael, Torrens Marta
机构信息
Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, PRBB, c/ Dr. Aiguader, 88, 08003 Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), PRBB, c/ Dr. Aiguader, 88, 08003 Barcelona. Spain.
IMIM (Hospital del Mar Medical Research Institute), PRBB, c/ Dr. Aiguader, 88, 08003 Barcelona. Spain; Institut de Neuropsiquiatria i Addiccions, Hospital del Mar, Passeig Marítim, 25-29, 08003 Barcelona, Spain; Psychiatry Department, Universitat Autònoma de Barcelona (UAB), Cerdanyola del Vallès, Spain.
出版信息
Eur Neuropsychopharmacol. 2020 Jul;36:167-168. doi: 10.1016/j.euroneuro.2020.06.009.
Abstract
摘要
相似文献
1
Cannabis research: Risks of recreational use and potential medical applications.大麻研究：娱乐性使用的风险与潜在医学应用
Eur Neuropsychopharmacol. 2020 Jul;36:167-168. doi: 10.1016/j.euroneuro.2020.06.009.
2
Marijuana Use and Potential Implications of Marijuana Legalization.大麻使用与大麻合法化的潜在影响。
Pediatr Rev. 2020 Feb;41(2):61-72. doi: 10.1542/pir.2018-0347.
3
Clinical issues in cannabis use.大麻使用的临床问题。
Br J Clin Pharmacol. 2018 Nov;84(11):2495-2498. doi: 10.1111/bcp.13703. Epub 2018 Aug 17.
4
Time to acknowledge the mixed effects of cannabis on health: a summary and critical review of the NASEM 2017 report on the health effects of cannabis and cannabinoids.是时候认识到大麻对健康的混合影响了：对 NASEM 2017 年关于大麻和大麻素对健康影响的报告进行总结和批判性审查。
Addiction. 2018 May;113(5):958-966. doi: 10.1111/add.14084. Epub 2017 Dec 21.
5
What Every Pediatric Gynecologist Should Know About Marijuana Use in Adolescents.每位儿科妇科医生都应了解的青少年大麻使用情况。
J Pediatr Adolesc Gynecol. 2019 Aug;32(4):349-353. doi: 10.1016/j.jpag.2019.03.004. Epub 2019 Mar 26.
6
Cannabis for Chronic Pain: Challenges and Considerations.大麻治疗慢性疼痛：挑战与考量。
Pharmacotherapy. 2018 Jun;38(6):651-662. doi: 10.1002/phar.2115. Epub 2018 May 16.
7
Social factors in marijuana use for medical and recreational purposes.用于医疗和娱乐目的的大麻使用中的社会因素。
Epilepsy Behav. 2017 May;70(Pt B):280-287. doi: 10.1016/j.yebeh.2016.11.011. Epub 2017 Jan 26.
8
Prevalence and correlates of medical cannabis patients' use of cannabis for recreational purposes.医用大麻患者将大麻用于娱乐目的的流行情况和相关因素。
Addict Behav. 2019 Jun;93:233-239. doi: 10.1016/j.addbeh.2019.02.003. Epub 2019 Feb 7.
9
Counseling Parents and Adolescents About Marijuana.就大麻问题为家长和青少年提供咨询。
Am Fam Physician. 2018 Jul 15;98(2):80-81.
10
Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms a Mile High.大麻与儿童炎症性肠病：一英里高空的变革之花
J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):265-271. doi: 10.1097/MPG.0000000000001393.
引用本文的文献
1
The Role of Cannabis in the Development of Psychosis.大麻在精神病发病机制中的作用。
Turk Psikiyatri Derg. 2024 Fall;35(3):234-244. doi: 10.5080/u27122.
2
A Case Report on Cannabinoid Hyperemesis Syndrome in Palliative Care: How Good Intentions Can Go Wrong.《癌症舒缓治疗中大麻素呕吐症候群之病例报告：好心可能办坏事》
Oncol Res Treat. 2022;45(7-8):438-443. doi: 10.1159/000524746. Epub 2022 May 3.
3
Jailhouse rock: health status, patterns of use, and subjective benefits of cannabis use in a sample of inmates in Spanish prisons.监狱摇滚：西班牙监狱中囚犯的健康状况、使用模式和使用大麻的主观获益。
Rev Esp Sanid Penit. 2022 Jan-Apr;24(1):9-14. doi: 10.18176/resp.00044.
本文引用的文献
1
Experiences with medical cannabis in the treatment of veterans with PTSD: Results from a focus group discussion.医用大麻治疗创伤后应激障碍退伍军人的经验：焦点小组讨论结果
Eur Neuropsychopharmacol. 2020 Jul;36:244-254. doi: 10.1016/j.euroneuro.2020.04.009. Epub 2020 Jun 20.
2
The impact of sex and cannabis on clinical features in first-admitted patients with psychosis.性与大麻对首发精神病患者临床特征的影响。
Eur Neuropsychopharmacol. 2020 Jul;36:235-243. doi: 10.1016/j.euroneuro.2020.03.003. Epub 2020 Apr 12.
3
Therapeutic potential of opioid/cannabinoid combinations in humans: Review of the evidence.阿片类药物/大麻素联合治疗在人类中的治疗潜力：证据综述。
Eur Neuropsychopharmacol. 2020 Jul;36:206-216. doi: 10.1016/j.euroneuro.2020.03.002. Epub 2020 Apr 6.
4
Adolescent cannabis use, cognition, brain health and educational outcomes: A review of the evidence.青少年大麻使用、认知、大脑健康和教育成果：证据综述。
Eur Neuropsychopharmacol. 2020 Jul;36:169-180. doi: 10.1016/j.euroneuro.2020.03.012. Epub 2020 Apr 5.
5
Neurobiological mechanisms underlying cannabis-induced memory impairment.大麻引起的记忆损伤的神经生物学机制。
Eur Neuropsychopharmacol. 2020 Jul;36:181-190. doi: 10.1016/j.euroneuro.2020.02.002. Epub 2020 Mar 2.
6
Possible therapeutic applications of cannabis in the neuropsychopharmacology field.大麻在神经精神药理学领域的可能治疗应用。
Eur Neuropsychopharmacol. 2020 Jul;36:217-234. doi: 10.1016/j.euroneuro.2020.01.013. Epub 2020 Feb 10.
7
Blunted highs: Pharmacodynamic and behavioral models of cannabis tolerance.迟钝的快感：大麻耐受性的药效学和行为学模型。
Eur Neuropsychopharmacol. 2020 Jul;36:191-205. doi: 10.1016/j.euroneuro.2020.01.006. Epub 2020 Feb 1.
8
CB2 Cannabinoid receptors as a therapeutic target-what does the future hold?大麻素 CB2 受体作为治疗靶点——未来前景如何？
Mol Pharmacol. 2014 Oct;86(4):430-7. doi: 10.1124/mol.114.094649. Epub 2014 Aug 8.
9
The endocannabinoid system and the brain.内源性大麻素系统与大脑。
Annu Rev Psychol. 2013;64:21-47. doi: 10.1146/annurev-psych-113011-143739. Epub 2012 Jul 12.
Zotero 插件